BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18430996)

  • 1. Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252a.
    Hübinger G; Geis S; LeCorre S; Mühlbacher S; Gordon S; Fracasso RP; Hoffman F; Ferrand S; Klafki HW; Roder HM
    J Alzheimers Dis; 2008 Apr; 13(3):281-94. PubMed ID: 18430996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture.
    Li X; Lu F; Tian Q; Yang Y; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2006 Jan; 113(1):93-102. PubMed ID: 15959856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
    Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An impedimetric microelectrode-based array sensor for label-free detection of tau hyperphosphorylation in human cells.
    Jahnke HG; Rothermel A; Sternberger I; Mack TG; Kurz RG; Pänke O; Striggow F; Robitzki AA
    Lab Chip; 2009 May; 9(10):1422-8. PubMed ID: 19417909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition.
    Liang Z; Zhang B; Su WW; Williams PG; Li QX
    ACS Chem Neurosci; 2016 Jul; 7(7):912-23. PubMed ID: 27213824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
    Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
    Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement.
    Baum L; Seger R; Woodgett JR; Kawabata S; Maruyama K; Koyama M; Silver J; Saitoh T
    Brain Res Mol Brain Res; 1995 Dec; 34(1):1-17. PubMed ID: 8750856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.
    Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ
    J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
    Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
    J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.
    Pope WB; Lambert MP; Leypold B; Seupaul R; Sletten L; Krafft G; Klein WL
    Exp Neurol; 1994 Apr; 126(2):185-94. PubMed ID: 7925819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Alzheimer-like tau hyperphosphorylation induced by simultaneous inhibition of phosphoinositol-3 kinase and protein kinase C in N2a cells.
    Xu GG; Deng YQ; Liu SJ; Li HL; Wang JZ
    Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):349-54. PubMed ID: 15880264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
    Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
    PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.
    Muñoz-Montaño JR; Moreno FJ; Avila J; Diaz-Nido J
    FEBS Lett; 1997 Jul; 411(2-3):183-8. PubMed ID: 9271202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1/2.
    Wisessaowapak C; Visitnonthachai D; Watcharasit P; Satayavivad J
    Environ Toxicol Pharmacol; 2021 May; 84():103626. PubMed ID: 33621689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
    Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.